Author:
Li Ying,Ji Chang Xue,Mei Li Hong,Qiang Jin Wei,Ju Shuai
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Ferenci, P. et al. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35, 716–721, doi: 10.1053/jhep.2002.31250 (2002).
2. Amodio, P. et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology 58, 325–336, doi: 10.1002/hep.26370 (2013).
3. Tapper, E. B. Rifaximin for the prevention of readmissions for patients with hepatic encephalopathy - the price is right. Liver Int 36, 1252–1254, doi: 10.1111/liv.2016.36.issue-9 (2016).
4. Marano, M. et al. Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy. Metab Brain Dis 30, 1445–1452, doi: 10.1007/s11011-015-9721-x (2015).
5. Rahelic, D., Kujundzic, M., Romic, Z., Brkic, K. & Petrovecki, M. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. Coll Antropol 30, 523–528 (2006).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献